TTI-101
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for TTI-101, covering 2025-02-21 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma [Phase 1, Phase 2]